Founded in Osaka in 1781, Takeda is a global Japanese biopharmaceutical company — now the third largest company of its kind in Asia. It focuses on oncology, rare diseases, neuroscience, gastroenterology, Plasma-Derived Therapies and vaccines.
For its Annual Integrated Report, Takeda wanted to articulate its long-term value creation model, much of which concerns PDTs, their dengue vaccine, and leading-edge oncology treatments. The client also wished to bring together diverse global organizations by showing regional impact by talking about their work not just in Japan, but also Brazil, Austria and the United States. The primary target audience for this report is stakeholders and investors, but another focus was employees, in order to build trust from within but also further differentiate Takeda’s positioning in the industry.
For the 2024 report I devised four distinct concepts that drew inspiration from both the meticulous precision of the company’s research and the quiet elegance of Japanese design and culture. The brand’s unusual primary color palette incorporates three different shades of red —— I was initially hesitant to use them together until I developed a dynamic motif of overlapping stripes that served as a visual anchor for the third concept. This was the one I eventually expanded upon for the finished report.
Another aspect that visually strengthened this report was its photography. Takeda conducted a series of new photoshoots in Japan and Brazil and I was able to leverage the beautiful results of those to produce full-page, full-bleed layouts with thoughtfully overlaid type. This not only broke up the repetition of the more text-heavy pages but also provided a certain magazine-like sophistication, something the client had specifically requested.
Concept A
Concept B
Concept C
Concept D
View the finished report here.